Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Journal of Psychopharmacology (Oxford, England)
|
October 15, 2015
Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences
Elizabeth M Tunbridge, Graham Dunn, Robin M Murray, et al.
Inflammatory Bowel Diseases
|
November 9, 2016
Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease
Ainsley M Robinson, Shakuntla V Gondalia, Avinash V Karpe, et al.
Microorganisms
|
October 9, 2019
Influence of Human Activities on Broad-Scale Estuarine-Marine Habitats Using Omics-Based Approaches Applied to Marine Sediments
Rohan M Shah, Joseph Crosswell, Suzanne S Metcalfe, et al.
Analytical Chemistry
|
May 6, 2010
Characterization of tetra-aryl benzene isomers by using preparative gas chromatography with mass spectrometry, nuclear magnetic resonance spectroscopy, and X-ray crystallographic methods
Christian P G Rühle, Julie Niere, Paul D Morrison, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 21, 2010
Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study
Emma Barkus, Paul D Morrison, D Vuletic, et al.
Clinical Pharmacokinetics
|
October 16, 2014
Population pharmacokinetic model of THC integrates oral, intravenous, and pulmonary dosing and characterizes short- and long-term pharmacokinetics
Jules A A C Heuberger, Zheng Guan, Olubukayo-Opeyemi Oyetayo, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 15, 2010
Disruption of frontal θ coherence by Δ9-tetrahydrocannabinol is associated with positive psychotic symptoms
Paul D Morrison, Judith Nottage, James M Stone, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 9, 2012
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Amir Englund, Paul D Morrison, Judith Nottage, et al.
Psychopharmacology
|
March 23, 2018
Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects
Mitul A Mehta, Anne Schmechtig, Vasileia Kotoula, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
September 19, 2016
Metabolic profiling and in vitro assessment of anthelmintic fractions of Picria fel-terrae Lour
Rasika Kumarasingha, Avinash V Karpe, Sarah Preston, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Journal of Psychopharmacology (Oxford, England)
|
October 15, 2015
Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences
Elizabeth M Tunbridge, Graham Dunn, Robin M Murray, et al.
Inflammatory Bowel Diseases
|
November 9, 2016
Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease
Ainsley M Robinson, Shakuntla V Gondalia, Avinash V Karpe, et al.
Microorganisms
|
October 9, 2019
Influence of Human Activities on Broad-Scale Estuarine-Marine Habitats Using Omics-Based Approaches Applied to Marine Sediments
Rohan M Shah, Joseph Crosswell, Suzanne S Metcalfe, et al.
Analytical Chemistry
|
May 6, 2010
Characterization of tetra-aryl benzene isomers by using preparative gas chromatography with mass spectrometry, nuclear magnetic resonance spectroscopy, and X-ray crystallographic methods
Christian P G Rühle, Julie Niere, Paul D Morrison, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 21, 2010
Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study
Emma Barkus, Paul D Morrison, D Vuletic, et al.
Clinical Pharmacokinetics
|
October 16, 2014
Population pharmacokinetic model of THC integrates oral, intravenous, and pulmonary dosing and characterizes short- and long-term pharmacokinetics
Jules A A C Heuberger, Zheng Guan, Olubukayo-Opeyemi Oyetayo, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 15, 2010
Disruption of frontal θ coherence by Δ9-tetrahydrocannabinol is associated with positive psychotic symptoms
Paul D Morrison, Judith Nottage, James M Stone, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 9, 2012
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Amir Englund, Paul D Morrison, Judith Nottage, et al.
Psychopharmacology
|
March 23, 2018
Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects
Mitul A Mehta, Anne Schmechtig, Vasileia Kotoula, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
September 19, 2016
Metabolic profiling and in vitro assessment of anthelmintic fractions of Picria fel-terrae Lour
Rasika Kumarasingha, Avinash V Karpe, Sarah Preston, et al.
Page
of 8